OrbiMed
PE/Buy-Out · New York (United States)
Sign up free to access full profile and submit your pitch.
About
OrbiMed Advisors LLC is a leading healthcare investment firm based in New York City, specializing in public and private investments across the healthcare and biotechnology sectors. Founded in 1998 by Samuel Isaly, Michael Sheffery, and Arvind Desai, OrbiMed has grown to become one of the world's largest dedicated healthcare investment firms, managing approximately $17 billion in assets as of March 2024. The firm's investment approach spans various stages of company development, from seed-stage startups to large multinational corporations, focusing on biopharmaceuticals, medical devices, diagnostics, and technology-enabled healthcare services. OrbiMed's global team of over 130 professionals operates across multiple locations, including New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, enabling the firm to provide tailored financing solutions and extensive resources to its portfolio companies. Notable achievements include raising over $4.3 billion across three private investment funds in October 2023, demonstrating strong investor confidence and the firm's commitment to driving innovation in the healthcare sector. Additionally, in May 2023, OrbiMed expanded its presence in Europe by opening a London office, further solidifying its position in the global healthcare investment landscape.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of OrbiMed
Other investors that have backed the same portfolio companies as OrbiMed. Expand any entry to see the shared portfolio companies.
- 52 shared
Shared portfolio companies
- ACADIA Pharmaceuticals Inc.
- Achilles Therapeutics plc
- Adaptimmune Therapeutics plc
- Adcendo ApS
- Adela, Inc.
- Adverum Biotechnologies, Inc.
- Alector, Inc.
- Alentis Therapeutics AG
- Apogee Therapeutics, Inc.
- Arcutis Biotherapeutics, Inc.
- ARS Pharmaceuticals, Inc.
- Arvinas, Inc.
- Ascendis Pharma A/S
- Athersys, Inc.
- Avalo Therapeutics, Inc.
- BioAge Labs, Inc.
- BioCryst Pharmaceuticals, Inc.
- Century Therapeutics, Inc.
- Convergent Therapeutics, Inc.
- Crinetics Pharmaceuticals, Inc.
- Edgewise Therapeutics, Inc.
- Electra Therapeutics, Inc.
- Enliven Therapeutics, Inc.
- Forward Therapeutics, Inc.
- Galecto, Inc.
- GentiBio, Inc.
- Invivyd, Inc.
- Jade Biosciences, Inc.
- Janux Therapeutics, Inc.
- KALA BIO, Inc.
- Keros Therapeutics, Inc.
- Larimar Therapeutics, Inc.
- MacroGenics, Inc.
- Magenta Medical LTD
- MBX Biosciences, Inc.
- Natera, Inc.
- Nautilus Biotechnology, Inc.
- Nucleix Ltd.
- Olema Pharmaceuticals, Inc.
- Pandion Operations, Inc.
- PMV Pharmaceuticals, Inc.
- ProfoundBio (Suzhou) Co., Ltd.
- Rampart Bioscience, Inc.
- Rhythm Pharmaceuticals, Inc.
- Scribe Therapeutics Inc.
- Sionna Therapeutics, Inc.
- Sparrow Pharmaceuticals, Inc.
- Star Therapeutics, Inc.
- Third Harmonic Bio, Inc.
- Tyra Biosciences, Inc.
- Verdiva Bio Limited
- X4 Pharmaceuticals, Inc.
- 26 shared
Shared portfolio companies
- Achilles Therapeutics plc
- Affimed N.V.
- Alector, Inc.
- Alterity Therapeutics Limited
- Apogee Therapeutics, Inc.
- Arvinas, Inc.
- Athenex, Inc.
- Caris Life Sciences, Inc.
- Crinetics Pharmaceuticals, Inc.
- Crossover Health Medical Group, APC
- CytomX Therapeutics, Inc.
- Edgewise Therapeutics, Inc.
- Forte Biosciences, Inc.
- Galecto, Inc.
- MeiraGTx Holdings plc
- Nautilus Biotechnology, Inc.
- RAPT Therapeutics, Inc.
- Rhythm Pharmaceuticals, Inc.
- Scribe Therapeutics Inc.
- Sionna Therapeutics, Inc.
- Sonendo, Inc.
- Spyre Therapeutics, Inc.
- Synlogic, Inc.
- ViewRay, Inc.
- VYNE Therapeutics Inc.
- Zentera Therapeutics
- 23 shared
Shared portfolio companies
- ADARx Pharmaceuticals, Inc.
- Adverum Biotechnologies, Inc.
- Arcutis Biotherapeutics, Inc.
- Ascendis Pharma A/S
- BlossomHill Therapeutics, Inc.
- Compass Therapeutics, Inc.
- GenFleet Therapeutics (Shanghai) Inc.
- KALA BIO, Inc.
- Larimar Therapeutics, Inc.
- MacroGenics, Inc.
- Mereo BioPharma Group plc
- Nabriva Therapeutics plc
- Neurogastrx, Inc.
- Olema Pharmaceuticals, Inc.
- ORIC Pharmaceuticals, Inc.
- Passage Bio, Inc.
- RemeGen, Ltd.
- Sinovac Biotech Ltd.
- Terns Pharmaceuticals, Inc.
- VISEN Pharmaceuticals (Shanghai) Co., Ltd.
- VYNE Therapeutics Inc.
- Whitehawk Therapeutics, Inc.
- Zai Lab Limited
- 22 shared
Shared portfolio companies
- Adaptimmune Therapeutics plc
- Adcendo ApS
- Alentis Therapeutics AG
- Asceneuron SA
- Convergent Therapeutics, Inc.
- Corvus Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals, Inc.
- Disc Medicine, Inc.
- Edgewise Therapeutics, Inc.
- Galecto, Inc.
- iECURE, Inc.
- Lysogene S.A.
- Magenta Medical LTD
- Minervax ApS
- NeRRe Therapeutics Ltd.
- ObsEva SA
- OnCusp Therapeutics, Inc.
- SI-BONE, Inc.
- Terremoto Biosciences, Inc.
- TherAchon SAS
- Windward Bio AG
- Xenon Pharmaceuticals Inc.
- 19 shared
Shared portfolio companies
- Adaptimmune Therapeutics plc
- Affimed N.V.
- ARYx Therapeutics, Inc.
- Avalo Therapeutics, Inc.
- Avenzo Therapeutics, Inc.
- Brenig Therapeutics, Inc.
- CHARM Therapeutics Inc.
- Cleave Therapeutics, Inc.
- Magenta Medical LTD
- MBX Biosciences, Inc.
- NeuroPace, Inc.
- ObsEva SA
- ORIC Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals, Inc.
- Roka Bioscience, Inc.
- Synlogic, Inc.
- Therachon AG
- X4 Pharmaceuticals, Inc.
- Xenon Pharmaceuticals Inc.
- 18 shared
Shared portfolio companies
- Achilles Therapeutics plc
- ADARx Pharmaceuticals, Inc.
- Alterome Therapeutics, Inc.
- Averna Therapeutics Inc.
- Convergent Therapeutics, Inc.
- Crinetics Pharmaceuticals, Inc.
- Cullinan Therapeutics, Inc.
- Edgewise Therapeutics, Inc.
- Erasca, Inc.
- Evox Therapeutics Limited
- Mirador Therapeutics, Inc.
- ORIC Pharmaceuticals, Inc.
- Ottimo Pharma Limited
- Scorpion Therapeutics, Inc.
- TigerConnect, Inc.
- Triveni Bio, Inc.
- Vicore Pharma Holding AB (publ)
- Whitehawk Therapeutics, Inc.
- 17 shared
Shared portfolio companies
- Alumis Inc.
- Avenzo Therapeutics, Inc.
- Candid Therapeutics, Inc.
- Compass Therapeutics, Inc.
- Corvus Pharmaceuticals, Inc.
- Crossover Health Medical Group, APC
- Delfi Diagnostics, Inc.
- Disc Medicine, Inc.
- Edgewise Therapeutics, Inc.
- ImageneBio, Inc.
- Lyell Immunopharma, Inc.
- Natera, Inc.
- Odyssey Therapeutics, Inc.
- Olema Pharmaceuticals, Inc.
- RAPT Therapeutics, Inc.
- RayThera, Inc.
- Syndax Pharmaceuticals, Inc.
- 15 shared
Shared portfolio companies
- Abbisko Therapeutics Co. Ltd.
- Apollomics, Inc.
- Arrail Group Limited
- Beijing Yuanxin Technology Group Co., Ltd.
- Candid Therapeutics, Inc.
- Epigenic Therapeutics Co., Ltd.
- Insilico Medicine, Inc.
- Renasant Bio, Inc.
- Shanghai Minghui Pharmaceutical (Shanghai) Limited
- Shanghai StairMed Technology Co., Ltd.
- Suzhou Zanrong Pharmaceutical Technology Co., Ltd.
- TandemAI US, LLC
- Windward Bio AG
- Wuxi Pulnovo Medical Technology Co., Ltd.
- Yidao Biotechnology (Suzhou) Co., Ltd.
- 15 shared
Shared portfolio companies
- Anthera Pharmaceuticals, Inc.
- ArriVent BioPharma, Inc.
- Ascendis Pharma A/S
- Avenzo Therapeutics, Inc.
- BioAge Labs, Inc.
- Edgewise Therapeutics, Inc.
- ENYO Pharma SA
- Natera, Inc.
- NextCure, Inc.
- ObsEva SA
- OnCusp Therapeutics, Inc.
- Prothena Corporation plc
- Star Therapeutics, Inc.
- Synlogic, Inc.
- VISEN Pharmaceuticals (Shanghai) Co., Ltd.
- 15 shared
Shared portfolio companies
- ADARx Pharmaceuticals, Inc.
- Alumis Inc.
- ARS Pharmaceuticals, Inc.
- Asceneuron SA
- Atox Bio Inc.
- Avenzo Therapeutics, Inc.
- CHARM Therapeutics Inc.
- Fore Biotherapeutics Inc.
- KALA BIO, Inc.
- Kartos Therapeutics, Inc.
- Odyssey Therapeutics, Inc.
- ORIC Pharmaceuticals, Inc.
- Pandion Operations, Inc.
- Telios Pharma, Inc.
- Windward Bio AG
.png)
